William Fenical and Satoshi Omura - The Scripps Research Institute
William Fenical and Satoshi Omura - The Scripps Research Institute
William Fenical and Satoshi Omura - The Scripps Research Institute
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Baran Group Meeting<br />
Wednesday,<br />
May 19, 2004<br />
Biography:<br />
Professor <strong>Satoshi</strong> <strong>Omura</strong><br />
-Bachelors degree from Yamanashi University<br />
-M.S. <strong>and</strong> Ph. D. from the Science University of Tokyo (1958)<br />
-Ph. D. in Pharmacy from University of Tokyo<br />
-Currently a professor <strong>and</strong> the president of the Kitasato <strong>Institute</strong> of Japan<br />
-<strong>Research</strong> focuses on the isolation <strong>and</strong> discovery of microorganisms as well as<br />
biologically interesting substances which they produce<br />
<strong>William</strong> <strong>Fenical</strong> <strong>and</strong> <strong>Satoshi</strong> <strong>Omura</strong><br />
Antibacterial:<br />
A-73A, aurantinins, factumycin, kinamycins,<br />
KM-8, LA-1, leucomycins, takaokamycin<br />
Bacterial cell wall synthesis inhibitor:<br />
AM-5289, asukamycin, azureomycin,<br />
nanaomycins, setomimycin, vineomycins<br />
Antifolate:<br />
AM-8402, diazaquinomycin<br />
Antimycoplasmal:<br />
2'-amino-2'-deoxyadenosine, cervinomycins,<br />
frenolicin B, OM-173<br />
Antianaerobic:<br />
clostomicin, luminamycin, lustromycin,<br />
thiotetromycin<br />
Antiviral:<br />
virantmycin, virustomycin<br />
Antifungal:<br />
AF-8 (albolleutin), cerulenin irumamycin,<br />
O-2867, prumycin<br />
Antiparasitic:<br />
avermectins, hitachimycin (stubomycin),<br />
setamycin<br />
Anticancer:<br />
OS-3256B, sporamycin<br />
Herbicidal:<br />
herbimycins, karabemycin<br />
Penicillinase inhibitor:<br />
KA-107<br />
Adenosine deaminase inhibitor:<br />
adechlorin<br />
Elastase inhibitor:<br />
elasnin<br />
Antiplatelet:<br />
OM-3209<br />
Mike DeMartino<br />
Biological diversity of Professor <strong>Omura</strong>'s isolated chemicals<br />
(Taken from Microbiological Reviews, 1986, 50, 259.)<br />
Alkaloid (chemical screening):<br />
AM-2504 (prolimycin), 1,3-diphenethylurea,<br />
herquline, NA-337 A, neoxaline, pyrindicin,<br />
quinoline-2-methanol, staurosporine, TM-64<br />
(narcoactine)<br />
Hybrid biosynthesis:<br />
chimeramycins, mederrhodins<br />
Chemical modification:<br />
rokitamycin (3"-O-propionylleucomycin A,<br />
5, 3,3",4"-tri-O-propionylspiramycin I,<br />
motilides<br />
Neuritogenesis inducer:<br />
lactacystin<br />
HMG-CoA synthase inhibitor:<br />
1233A<br />
Acyl-CoA synthetase inhibitor:<br />
triacsins<br />
Acyl-CoA:cholesterol acyl-transferase (ACAT)<br />
inhibitor:<br />
pyripyropenes, terpendole, purpactines,<br />
glisoprenin<br />
Glutamine synthetase inhibitor:<br />
phosalacine, oxetin<br />
Protein farnesyltransferase inhibitor:<br />
pepticinnamin, gliotoxin<br />
Cellulose biosynthesis inhibitor:<br />
phthoramycin, phthoxazolin<br />
Anticoccidial:<br />
cytosaminomycin, fudecalone, hynapene<br />
Gp-12-CD4 binding inhibitor:<br />
chloropeptin, isochromophilones<br />
Acetylcholine esterase inhibitor:<br />
arisugacin<br />
Others:<br />
irumanolides, protylonolide
Baran Group Meeting<br />
#29<br />
Macrosphelides<br />
#30<br />
Staurosporine<br />
#28<br />
Madindolines<br />
<strong>William</strong> <strong>Fenical</strong> <strong>and</strong> <strong>Satoshi</strong> <strong>Omura</strong><br />
#31<br />
Trienomycins<br />
<strong>and</strong><br />
Mycotrienins<br />
#32<br />
(+)-Lactacystin<br />
HO 2C<br />
AcHN<br />
S<br />
HO<br />
O<br />
HO<br />
Me<br />
#36<br />
Nafuredin<br />
N<br />
H<br />
Me<br />
Me<br />
O<br />
#34<br />
Hitachimycin<br />
#35<br />
Purpactins<br />
#37<br />
Avermectins<br />
Mike DeMartino<br />
#33<br />
Pyripyropenes
Baran Group Meeting<br />
Biography:<br />
-Born in 1941, Chicago, Illinois<br />
Professor <strong>William</strong> <strong>Fenical</strong><br />
-B.S. in Biochemistry from California State Polytechnic University (1963)<br />
-M.S. in organic chemistry from San Jose State University (1965)<br />
-Ph. D. with professor D. R. Radlick at University of California, Riverside<br />
(1969)<br />
-Began at <strong>Scripps</strong> <strong>Institute</strong> of Oeanography (SIO) as an assistant professor<br />
in 1973<br />
-Became a professor of oceanography at SIO in 1983<br />
-Became Director of Marine <strong>Research</strong> in 1989<br />
<strong>William</strong> <strong>Fenical</strong> <strong>and</strong> <strong>Satoshi</strong> <strong>Omura</strong><br />
#1<br />
Scytalidamides<br />
#3<br />
Tam<strong>and</strong>arins<br />
#4<br />
Salinamides<br />
Mike DeMartino<br />
#2<br />
Mangicols
Baran Group Meeting<br />
O<br />
#7<br />
Ningalins<br />
H<br />
Cl<br />
H<br />
N<br />
Me<br />
OH<br />
O<br />
O<br />
#5<br />
Salinosporamide A<br />
#8<br />
Didemninides<br />
<strong>William</strong> <strong>Fenical</strong> <strong>and</strong> <strong>Satoshi</strong> <strong>Omura</strong><br />
#6<br />
Neomangicols<br />
#9<br />
Neoverrucosane<br />
#12<br />
Sterol Glycosides<br />
#10<br />
Trichodermamides<br />
Me Me<br />
HO<br />
OH<br />
#13<br />
eunicellane diterpenoid; heterogorgiolide<br />
Mike DeMartino<br />
O<br />
H<br />
O<br />
MeO<br />
#11<br />
Pestalone<br />
OH<br />
Cl<br />
Cl<br />
Me
Baran Group Meeting<br />
N<br />
O<br />
N<br />
Me<br />
NH<br />
O<br />
N<br />
O<br />
O<br />
H<br />
#18<br />
Cyclomarins<br />
NH<br />
i-Bu<br />
#15<br />
Luisols<br />
A & B<br />
N<br />
O<br />
N<br />
#17<br />
Fumiquinazolines H & I<br />
Me<br />
N<br />
NH<br />
O<br />
O<br />
OH<br />
H<br />
Me<br />
NH<br />
<strong>William</strong> <strong>Fenical</strong> <strong>and</strong> <strong>Satoshi</strong> <strong>Omura</strong><br />
i-Bu<br />
Me<br />
H<br />
H<br />
Me<br />
#14<br />
Arenaric Acid<br />
O<br />
#19<br />
Eleutherobin<br />
O<br />
#16<br />
Cyclized Didemninide<br />
O<br />
Me<br />
OMe<br />
O<br />
OAc<br />
O<br />
N<br />
OH<br />
OH<br />
N Me<br />
HO<br />
Me<br />
O<br />
O<br />
Me<br />
#25<br />
Thraustochytrosides<br />
O<br />
#20<br />
Octalactins A & B<br />
O<br />
Me<br />
OH<br />
#21<br />
Diazonamides<br />
#26<br />
Aplidiamine<br />
#23<br />
Aspergillamides<br />
HO<br />
Me<br />
O<br />
O<br />
Mike DeMartino<br />
Me<br />
#22<br />
Aspergilloxides<br />
#27<br />
Polycarpine<br />
Dihydrochloride<br />
O<br />
Me<br />
OH<br />
#24<br />
Labiatamides
Baran Group Meeting<br />
LREIMS: m/z = 438/440/442<br />
->C21 H20 O6 Cl2<br />
-11 Degrees of Unsaturation<br />
IR<br />
-Benzaldehyde<br />
-Ketone<br />
-Hydroxyl groups<br />
UV: Aromatic Ring with<br />
extended chromophore<br />
<strong>William</strong> <strong>Fenical</strong> <strong>and</strong> <strong>Satoshi</strong> <strong>Omura</strong><br />
Isolation of Pestalone<br />
-"...potent antibacterial activity aganist drug-resistant bacteria."<br />
-Isolated as yellow crystals (Yes you could just do crystallography, but that's no fun!)<br />
Me Me<br />
HO<br />
OH<br />
O<br />
H<br />
O<br />
MeO<br />
NMR<br />
Proton: Two olefinic methyl groups<br />
One Aromatic resonance<br />
methoxy group<br />
three exchangable phenols<br />
aldehyde<br />
Carbon: Alhyde <strong>and</strong> ketone confirmed<br />
Lots of aromatic/vinylic quat carbons<br />
One aromatic double<br />
OH<br />
2D NMR: Isoprene Fragment<br />
-other modest asignments<br />
Cl<br />
Cl<br />
Me<br />
Mike DeMartino
Me<br />
Me<br />
Baran Group Meeting<br />
-Total Synthesis of (+)-Lactacystin<br />
J. Am. Chem. Soc. 1996, 118, 3584.<br />
A<br />
Jones<br />
1. 2N KOH<br />
2. H 2, Pd(OH) 2<br />
98%<br />
1. LHMDS,<br />
H 2CO, 85%<br />
2. DMSO, DCC<br />
OH<br />
Ph(Me) 2COOH<br />
Ti(O - i - Pr) 4,<br />
(+)-DIPT<br />
82%<br />
Me<br />
Me<br />
Me<br />
Me<br />
Me<br />
Me<br />
O NBn<br />
O<br />
OH<br />
O N<br />
Ph<br />
HO 2C<br />
NH 2<br />
AcHN<br />
Me<br />
CO 2H<br />
CO 2H<br />
CO2Me CHO<br />
Me<br />
S<br />
HO<br />
HO<br />
O<br />
Me<br />
(+)-Lactacystin<br />
O<br />
N<br />
H<br />
Me<br />
OH<br />
Me<br />
1. CH 2N 2<br />
2. KOH<br />
EtOH<br />
96%<br />
<strong>William</strong> <strong>Fenical</strong> <strong>and</strong> <strong>Satoshi</strong> <strong>Omura</strong><br />
NaH<br />
BnNCO<br />
1. HCl (g),<br />
MeOH, 100%<br />
2. PhC(OMe) 3<br />
82%<br />
[Ipc-(+)] 2B<br />
O<br />
70%, 4:1<br />
HO<br />
Me<br />
A<br />
Me<br />
BnN O<br />
Me<br />
Me<br />
Me<br />
O<br />
O NBn<br />
O<br />
Me<br />
75% Total<br />
Me<br />
Me<br />
OH<br />
O NBn<br />
Me<br />
O<br />
O N<br />
Ph<br />
MeO2C Me<br />
CO 2H<br />
CO 2Me<br />
O<br />
N<br />
NaH<br />
THF<br />
HO Me<br />
Ph<br />
1. O 3, DMS<br />
2. NaClO 2,<br />
NaH 2PO 3<br />
68%<br />
1. O.1 N NaOH<br />
82%<br />
2. BOPCl, Et 3N<br />
AcHN<br />
CO 2Allyl<br />
79%<br />
SH<br />
MeO2C Me<br />
Me<br />
AllylO 2C<br />
AcHN<br />
HO Me<br />
O<br />
N<br />
S<br />
HO<br />
CO 2H<br />
Ph<br />
HO<br />
O<br />
Me<br />
N<br />
H<br />
Me<br />
Me<br />
O<br />
Pd,<br />
NH 4O 2CH<br />
Pd(PPh 3) 4, HCO 2H<br />
Et 3N, 81%<br />
Mike DeMartino<br />
HO 2C<br />
MeO 2C<br />
AcHN<br />
HO<br />
HO<br />
Me<br />
S<br />
HO<br />
N<br />
H<br />
Me<br />
HO<br />
O<br />
Me<br />
Me<br />
(+)-Lactacystin<br />
O<br />
N<br />
H<br />
Me<br />
Me<br />
O
Baran Group Meeting<br />
-Total Synthesis of Octalins A & B<br />
Keith Buszek: J. Am. Chem. Soc. 1994, 116, 5511.<br />
HO<br />
Me<br />
1. DMP<br />
2. N 2CHPO(OMe) 2,<br />
t-BuOK<br />
1. H 2, Pd/CaCO 3<br />
2. Ac 2O, DMAP, py<br />
2. PPTS<br />
3. H 2, Pd/C<br />
O<br />
O<br />
1. 2,2' pyridinedisulfide<br />
PPh 3;<br />
AgBF 4,<br />
Refluxing PhMe<br />
63-75%<br />
2. TBAF<br />
Me<br />
O<br />
TBDPSO<br />
Me<br />
O<br />
Me<br />
Me<br />
OMPM<br />
OH<br />
OMPM<br />
Me<br />
Me<br />
HO<br />
Octalactin A Octalactin B<br />
TBDPSO OAc<br />
MPMO<br />
Me<br />
Me<br />
Me<br />
1. 9-BBN; H 2O 2<br />
2. MMTrCl, Base<br />
3. TBAF<br />
1. I 2, Morpholine<br />
HO<br />
OMMTr<br />
2. CrCl2 (1.0%<br />
w/w NiCl2) CHO<br />
TBDPSO<br />
O<br />
O<br />
Me<br />
Me<br />
Me<br />
4hr, rt 75-90% (1:1)<br />
OMPM<br />
OH<br />
I<br />
OH<br />
1. DMP;<br />
NaClO 2<br />
2. K 2CO 3<br />
MeOH<br />
1. DMP<br />
2. CrCl 2 (0.1%<br />
w/w NiCl 2)<br />
Me<br />
OTBS<br />
74% 1.5:1<br />
Me<br />
<strong>William</strong> <strong>Fenical</strong> <strong>and</strong> <strong>Satoshi</strong> <strong>Omura</strong><br />
O<br />
O<br />
Me<br />
Me<br />
O<br />
OMPM<br />
Me<br />
TBDPSO OH<br />
MPMO<br />
Me<br />
Me<br />
Me<br />
OH<br />
OMMTr<br />
TBDPSO OH<br />
Me<br />
O<br />
O<br />
Me<br />
Me<br />
Me<br />
OH<br />
Me<br />
OMPM<br />
Me<br />
Me<br />
OMPM<br />
OMMTr<br />
CO 2H<br />
OTBS<br />
Me<br />
Me<br />
1. DMP<br />
2. HF<br />
3. DDQ, H 2O<br />
1. t-BuOOH,<br />
VO(acac) 2<br />
2. DMP<br />
3. HF<br />
4. DDQ, H 2O<br />
HO<br />
Me<br />
HO<br />
Me<br />
O<br />
O<br />
O<br />
O<br />
Me Me<br />
Octalactin B<br />
O<br />
Me<br />
O<br />
O<br />
Me<br />
Octalactin A<br />
OH<br />
OH<br />
Me<br />
Me<br />
Me<br />
Me<br />
Mike DeMartino
Baran Group Meeting<br />
-Total Synthesis of Eleutherobin<br />
K.C. Nicolaou: Angew. Chem. Int. Ed. Engl. 1997, 36, 2520.<br />
O<br />
O<br />
1. HCCMgBr<br />
2. TBAF<br />
1. TPAP,<br />
NMO<br />
2. CNCH 2CO 2Et<br />
Base<br />
O SPh<br />
OH<br />
Me<br />
H<br />
H<br />
Me Me<br />
A<br />
Me<br />
H<br />
H<br />
Me Me<br />
CHO<br />
OTBS<br />
(+)-carvone derived<br />
Me<br />
H<br />
H<br />
Me Me<br />
OH OH<br />
Me<br />
OH<br />
Me TESO<br />
H<br />
H<br />
Me Me<br />
1. NaH; PMB-Cl<br />
2. TsOH<br />
3. TBSOTf, Et 3N<br />
CN<br />
OTES<br />
Me<br />
CO 2Et<br />
O<br />
O<br />
O<br />
Me<br />
OMe<br />
O OAc<br />
O<br />
Eleutherobin<br />
N<br />
1. H 2C=CHOEt,<br />
t-BuLi;<br />
<strong>The</strong>n A<br />
2. H 2SO 4<br />
1. TESOTf<br />
Et 3N<br />
2. PPTS<br />
Dibal<br />
O SPh<br />
OPMB<br />
OTBS<br />
TBSO<br />
OH<br />
OH<br />
<strong>William</strong> <strong>Fenical</strong> <strong>and</strong> <strong>Satoshi</strong> <strong>Omura</strong><br />
N Me<br />
Me<br />
H<br />
H<br />
Me Me<br />
1. NBS, py<br />
2. NaH<br />
Cl 3CCN<br />
OH<br />
O<br />
Me<br />
OTBS<br />
Me TESO<br />
H<br />
H<br />
Me Me<br />
OH<br />
Me TESO<br />
H<br />
H<br />
Me Me<br />
O<br />
OTBS<br />
TBSO<br />
OTES<br />
Me<br />
CHO<br />
OTES<br />
Me<br />
OH<br />
OC(NH)CCl3 OPMB<br />
TMSOTf<br />
b = 54%<br />
a = 28%<br />
1. DDQ, H 2O<br />
2. Ac 2O<br />
DMAP, Et 3N<br />
Me TESO<br />
H<br />
H<br />
Me Me<br />
O<br />
CHO<br />
OTES<br />
Me<br />
O<br />
OPMB<br />
OTBS<br />
O<br />
TESO<br />
Me Me<br />
H<br />
OTES<br />
H<br />
Me Me<br />
1. PPTS, MeOH<br />
2. Et 3N, DMAP<br />
O<br />
O<br />
N<br />
3. TBAF<br />
O OAc<br />
O<br />
O<br />
N Me<br />
OTBS<br />
OTBS<br />
OTBS<br />
1. LHMDS<br />
2. DMP<br />
1. Et 3N•3HF<br />
2. H 2, Pd/CaCO 3<br />
Me<br />
H<br />
H<br />
Me Me<br />
O<br />
O<br />
O<br />
Me<br />
Mike DeMartino<br />
TESO<br />
Me Me<br />
H<br />
OTES<br />
H<br />
Me Me<br />
OMe<br />
O OAc<br />
O<br />
Eleutherobin<br />
Me<br />
H<br />
H<br />
Me Me<br />
N<br />
OH<br />
OH<br />
O<br />
N Me<br />
O<br />
OPMB<br />
OTBS<br />
O<br />
O<br />
OH<br />
Me<br />
OH<br />
O OAc<br />
O<br />
OTBS<br />
OTBS<br />
OTBS
Baran Group Meeting<br />
-Total Synthesis of Eleutherobin<br />
Samuel Danishefsky: J. Am. Chem. Soc. 1999, 121, 6563.<br />
Me<br />
Me<br />
Me<br />
a-phell<strong>and</strong>rene<br />
Me<br />
Cl 3CCHO<br />
Zn, 0°C,<br />
Sonication<br />
Cl<br />
O<br />
Cl<br />
65%<br />
Me<br />
H<br />
H<br />
Me<br />
NMe 2<br />
O<br />
Me<br />
Me<br />
H<br />
H<br />
Me<br />
Cl<br />
Cl<br />
t-BuOCH(NMe) 2 TsOH,<br />
1. H + , H 2O<br />
2. n-BuLi<br />
Br<br />
O<br />
Br<br />
1.3:1<br />
3. TBDPSCl,<br />
Im., DMAP<br />
CrCl 2 (5eq)<br />
NiCl 2 (1eq)<br />
74%, 15:1<br />
DMDO/Acetone<br />
94%<br />
Me<br />
Me<br />
H<br />
Me<br />
Me<br />
H CO O<br />
2Me<br />
Me<br />
Me<br />
H<br />
H<br />
Me<br />
Me<br />
H<br />
H<br />
Me<br />
OTBDPS<br />
O<br />
O<br />
Br<br />
OTBDPS<br />
OH<br />
O<br />
MeOH<br />
1. Dibal<br />
2. MsCl<br />
3. KCN<br />
4. Dibal<br />
1. PivCl, Et 3N<br />
DMAP<br />
2.TBAF<br />
<strong>William</strong> <strong>Fenical</strong> <strong>and</strong> <strong>Satoshi</strong> <strong>Omura</strong><br />
Zn,<br />
MeOH<br />
Me<br />
Me<br />
Me<br />
Me<br />
Me<br />
H<br />
Me<br />
H<br />
H<br />
Me<br />
Me<br />
H<br />
H<br />
Me<br />
Me<br />
H<br />
O<br />
H Me<br />
H<br />
OH<br />
OPv<br />
1. TMSOTf<br />
2. MeLi<br />
Me<br />
H<br />
Me<br />
H<br />
Me<br />
Me<br />
O<br />
H CO 2Me<br />
OMe<br />
OMe<br />
OTBDPS<br />
O<br />
CHO<br />
OH<br />
O<br />
O<br />
OPv<br />
HO<br />
H Me<br />
OTMS<br />
OPv<br />
Br<br />
HO<br />
TsOH (cat)<br />
MeOH<br />
90%<br />
LHMDS;<br />
Comins' Rgt.<br />
1. TBAF<br />
2. DCC, DMAP<br />
O<br />
3. PPTS<br />
N<br />
Me<br />
N Me<br />
Me<br />
Me<br />
H<br />
H<br />
Me<br />
Me<br />
H<br />
H<br />
Me<br />
Me<br />
OH<br />
Me<br />
O<br />
OMe<br />
OPv<br />
OTBS<br />
Me<br />
O<br />
OMe<br />
OTf<br />
Me<br />
H<br />
H<br />
Me<br />
O<br />
O<br />
Bu 3Sn<br />
O<br />
Me<br />
OMe<br />
O OAc<br />
O<br />
Eleutherobin<br />
1. TBSOTf<br />
2. TPAP,<br />
NMO<br />
Pd(PPh) 3<br />
LiCl<br />
O OAc<br />
O<br />
50%<br />
N<br />
OH<br />
OH<br />
O<br />
N Me<br />
O<br />
Mike DeMartino<br />
Me<br />
Me<br />
Me<br />
H<br />
H<br />
Me<br />
Me<br />
H<br />
H<br />
Me<br />
OTBS<br />
Me<br />
O<br />
O<br />
O<br />
OMe<br />
OTBS<br />
Me<br />
OMe<br />
O OAc<br />
O<br />
O<br />
O
Me<br />
Baran Group Meeting<br />
-Total Synthesis of Eleutherobin<br />
Jeffery Winkler: Org. Lett. 2003, 5, 1805.<br />
Me<br />
O<br />
MeO 2C<br />
AgNO 3<br />
SiO 2<br />
79%<br />
BaMnO 4<br />
1. Dibal, 96%<br />
2. VO(acac) 2<br />
t-BuOOH<br />
66%<br />
Br<br />
Br<br />
Me<br />
S<br />
O<br />
O<br />
Me<br />
SnCl 2<br />
NaI<br />
86%<br />
SnCl 2, NaI<br />
72%<br />
S<br />
O<br />
O<br />
Me<br />
CHO<br />
Me<br />
H<br />
Me<br />
H<br />
S<br />
O<br />
O<br />
Me<br />
Me<br />
O<br />
O<br />
Me<br />
Me<br />
O<br />
H<br />
O<br />
Me Me OH<br />
Me<br />
H<br />
Me<br />
O<br />
Me<br />
OH<br />
H<br />
OH<br />
O<br />
Me Me OTBS<br />
Me<br />
OH<br />
OH<br />
Me<br />
CO 2Me<br />
NaHCO 3<br />
PhMe<br />
Reflux<br />
94%<br />
A<br />
TBSOTf<br />
51%<br />
<strong>William</strong> <strong>Fenical</strong> <strong>and</strong> <strong>Satoshi</strong> <strong>Omura</strong><br />
DMP<br />
1. NaOH (aq)<br />
2. NaIO 4<br />
66%<br />
Dibal<br />
S<br />
O<br />
O<br />
Me<br />
Me<br />
O<br />
Me Me<br />
A<br />
Me<br />
Me<br />
Me<br />
H<br />
O<br />
Me<br />
OH<br />
Me<br />
O<br />
O OH<br />
Me<br />
O<br />
H<br />
O<br />
Me Me OTBS<br />
Me<br />
H<br />
Me<br />
O<br />
H<br />
OH O<br />
Me Me OH<br />
OH<br />
SmI 2<br />
NiI 2(cat)<br />
72%<br />
VO(acac) 2<br />
t-BuOOH;<br />
Et 3N, SiO 2<br />
MeI, Ag 2O<br />
CaCO 3, 76%<br />
Me<br />
H<br />
Me<br />
OH<br />
H<br />
OH O<br />
Me Me OH<br />
Me Me<br />
H OH OH<br />
H<br />
O<br />
Me Me O<br />
Me<br />
Me<br />
H<br />
H<br />
Me<br />
O<br />
O<br />
OH Me<br />
O O<br />
Me<br />
OMe<br />
Me<br />
H<br />
H<br />
Me<br />
O<br />
O<br />
O<br />
Me<br />
OMe<br />
O OAc<br />
O<br />
Eleutherobin<br />
(COCl) 2<br />
py, 79%<br />
K 2CO 3<br />
MeOH<br />
N<br />
OH<br />
OH<br />
Mike DeMartino<br />
N Me<br />
Me Me<br />
H OH<br />
H<br />
O<br />
Me Me O<br />
Me<br />
Me<br />
H<br />
H<br />
Me<br />
O<br />
O<br />
OH Me<br />
O O<br />
OH
1. Hg(OTFA) 2,<br />
KI<br />
2. I 2<br />
Baran Group Meeting<br />
-Total Synthesis of Fumiquinazolines H & I<br />
Barry Snider: J. Org. Chem. 2003, 68, 545.<br />
Me<br />
A<br />
DMDO<br />
MeOH, 45%<br />
TrocHN<br />
1. H 2, Pd<br />
CO 2Me<br />
N<br />
H<br />
TrocHN<br />
TrocHN<br />
HO<br />
TrocHN<br />
N<br />
O<br />
N<br />
2. SiO 2 N<br />
1. BH 3•THF/TFA<br />
2. Cbz-L-Leu, DCC<br />
O<br />
N<br />
CO 2Me<br />
N<br />
CO 2Me<br />
O<br />
O<br />
O<br />
NH<br />
O<br />
O<br />
O<br />
N<br />
H<br />
3. DDQ<br />
82-95% N<br />
I<br />
OMe<br />
NHCbz<br />
i-Bu<br />
NCbz<br />
NH<br />
H<br />
NH<br />
i-Bu<br />
O<br />
Fumiquinazoline H<br />
i-Bu<br />
i-Bu<br />
N<br />
O<br />
<strong>William</strong> <strong>Fenical</strong> <strong>and</strong> <strong>Satoshi</strong> <strong>Omura</strong><br />
TrocHN<br />
O<br />
Pd 2(dba) 3, P(o-tolyl) 3<br />
K 2CO 3, PhMe, reflux<br />
NaBH 4<br />
N<br />
CO 2Me<br />
NHCbz<br />
i-Bu<br />
TrocHN<br />
TrocHN<br />
HO<br />
AcOH, 80% N<br />
FmocCl<br />
Hunig's Base<br />
Me<br />
N<br />
NH<br />
O<br />
OH<br />
H<br />
NH<br />
i-Bu<br />
O<br />
Fumiquinazoline I<br />
TrocHN<br />
N<br />
O<br />
O<br />
A<br />
O<br />
H<br />
CO 2Me<br />
N<br />
O<br />
CO 2Me<br />
O<br />
H<br />
NFmoc<br />
i-Bu<br />
NCbz<br />
NCbz<br />
i-Bu<br />
i-Bu<br />
A<br />
1. Zn, AcOH<br />
2. Anthranilic Acid<br />
EDCI<br />
PPh 3, Br 2<br />
Et 3N<br />
CH 3CN<br />
Reflux<br />
1. SiO 2<br />
2. Zn, HOAc<br />
3. Antrhanilic Acid<br />
EDCI<br />
4. Fmoc-L-Ala<br />
NH2 H<br />
N<br />
O<br />
N<br />
N<br />
N<br />
O<br />
H<br />
N<br />
O<br />
N<br />
O<br />
N<br />
O<br />
O<br />
Me<br />
N<br />
O<br />
O<br />
O<br />
HO<br />
N<br />
H<br />
NFmoc<br />
i-Bu<br />
SePh<br />
NHFmoc<br />
O<br />
N<br />
H<br />
NFmoc<br />
NH<br />
O<br />
OH<br />
O<br />
H<br />
NCbz<br />
N<br />
O<br />
O<br />
O<br />
i-Bu<br />
NH<br />
H<br />
EDCI<br />
Fmoc-L-NHCH(CH 2SePh)CO 2H<br />
i-Bu<br />
NFmoc<br />
i-Bu<br />
NH<br />
34%<br />
1. PPh 3, Br 2<br />
Et 3N<br />
2. piperdine<br />
3. CH 3CN<br />
Reflux<br />
4. H 2, Pd<br />
Mike DeMartino<br />
N<br />
H<br />
N<br />
N<br />
O<br />
O<br />
HO<br />
N<br />
H<br />
N<br />
N<br />
O<br />
N<br />
O<br />
SePh<br />
N<br />
O<br />
O<br />
SePh<br />
N<br />
NH 2<br />
N<br />
N<br />
NHFmoc<br />
O<br />
O<br />
Me<br />
N<br />
O<br />
O<br />
O<br />
H<br />
H<br />
NH<br />
O<br />
O<br />
Me<br />
N<br />
NH<br />
NFmoc<br />
i-Bu<br />
NFmoc<br />
H<br />
O<br />
OH<br />
H<br />
NH<br />
Fumiquinazoline H<br />
NH<br />
i-Bu<br />
i-Bu<br />
i-Bu<br />
O<br />
Fumiquinazoline I
Baran Group Meeting<br />
<strong>William</strong> <strong>Fenical</strong> <strong>and</strong> <strong>Satoshi</strong> <strong>Omura</strong><br />
<strong>The</strong> Baran Lab's Retrosnythetic Analysis of Luisols A <strong>and</strong>/or B:<br />
Mike DeMartino
Baran Group Meeting<br />
<strong>William</strong> <strong>Fenical</strong> <strong>and</strong> <strong>Satoshi</strong> <strong>Omura</strong><br />
References<br />
Selected Natural Products:<br />
1. J. Org. Chem. 2003, 68, 8767.<br />
2. J. Org. Chem. 2000, 65, 4843.<br />
3. J. Org. Chem. 2000, 65, 782.<br />
4. J. Org. Chem. 1999, 64, 1145.<br />
5. Angew. Chem Int. Ed. 2003, 42, 355.<br />
6. J. Org. Chem. 1996, 63, 8346.<br />
7. J. Org. Chem. 1997, 62, 3254.<br />
8. J. Org. Chem. 1997, 62, 1486.<br />
9. J. Nat. Prod. 2003, 66, 818.<br />
10. J. Nat. Prod. 2003, 66, 423.<br />
11. J. Nat. Prod. 2001, 64, 1444.<br />
12. J. Nat. Prod. 2000, 63, 1427.<br />
13. J. Nat. Prod. 1999, 62, 1322.<br />
14. J. Nat. Prod. 1999, 62, 605.<br />
15. J. Nat. Prod. 1999, 62, 608.<br />
16. J. Nat. Prod. 1999, 62, 389.<br />
17. Chem. Eur. J. 2000, 6, 1355.<br />
18. J. Am. Chem. Soc. 1999, 121, 11273.<br />
19. J. Am. Chem. Soc. 1997, 119, 8744.<br />
20. J. Am. Chem. Soc. 1991, 113, 4682.<br />
21. J. Am. Chem. Soc. 1991, 113, 2303.<br />
22. Org. Lett. 2002, 4, 1583.<br />
23. Tetrahedron 1998, 54, 13459.<br />
24. Tetrahedron 1996, 52, 2735.<br />
25. Tetrahedron Lett. 1999, 40, 7637.<br />
26. Tetrahedron Lett. 1997, 38, 941.<br />
27. Tetrahedron Lett. 1996, 37, 2369.<br />
28. J. Am. Chem. Soc. 2000, 122, 2122.<br />
29. J. Am. Chem. Soc. 1997, 119, 10247.<br />
30. Bioorg. Med. Chem. Lett. 1996, 16, 1893.<br />
31. J. Am. Chem. Soc. 1996, 118, 8308.<br />
32. J. Am. Chem. Soc. 1996, 118, 3584.<br />
33. J. Am. Chem. Soc. 1994, 116, 12097.<br />
34. J. Am. Chem. Soc. 1992, 114, 8003.<br />
35. J. Org. Chem. 1992, 57, 1271.<br />
36. Org. Lett. 2001, 3, 2289.<br />
37. Tetrahedron Lett. 2004, 45, 2507.<br />
Mike DeMartino